Bd and biosero collaborate to enable robotic integration with flow cytometers used in drug discovery and development

Franklin lakes, n.j. and san diego , jan. 23, 2025 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, and biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, today announced a framework collaboration agreement to enable and facilitate robotic arm integration with bd flow cytometry instruments to accelerate drug discovery and development.
BDX Ratings Summary
BDX Quant Ranking